UCSF Pediatrics’ Post

View organization page for UCSF Pediatrics, graphic

1,686 followers

A new UCSF study reveals that administering a second dose of BMZ—a steroid used to protect against severe brain bleeds—at the right time can significantly reduce risks for infants born before 28 weeks. This research provides clinicians with essential insights to refine steroid treatment timing protocols and improve the chances of healthy development for these newborns.

Timing is Everything: New UCSF Study Offers Hope for Reducing Brain Bleeds in Preterm Babies

Timing is Everything: New UCSF Study Offers Hope for Reducing Brain Bleeds in Preterm Babies

pediatrics.ucsf.edu

To view or add a comment, sign in

Explore topics